Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
The ATR inhibitor elimusertib exhibits anti-lymphoma acti... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
The ATR inhibitor elimusertib exhibits anti-lymphoma activity and synergizes with the PI3K inhibitor copanlisib
0
Authors
Giulio Sartori
19 more
Giulio Sartori
•
Emanuele Zucca
17 more
•
Francesco Bertoni
Published
February 12, 2023
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to review
Share your thoughts on this paper...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Preprint Server
Topics
Biology
Biochemistry
Chemistry
Cancer Oncology
Immunology
Show all topics
DOI
10.1101/2023.02.10.528011
License
cc-no
Supporters
Support the authors with ResearchCoin
Tip RSC
Preprint Server
Topics
Biology
Biochemistry
Chemistry
Cancer Oncology
Immunology
Show all topics
DOI
10.1101/2023.02.10.528011
License
cc-no
